Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK/PD Profile Comparison of Tentin vs Magisterial Dexamfetamine in ADHD (DAVE)
NCT05621174Active, not recruiting
- Sponsor
- University of Amsterdam
- Start
- Apr 2023
- Primary completion
- Dec 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of dextroamphetamine in attention deficit hyperactivity disorder (ADHD) (2 arms), sponsored by University of Amsterdam. Primary endpoints: Quantified behavior Test - Time Active, Quantified behavior Test - Distance and 6 more. Started Apr 2023; status: active, not recruiting.
02
Drugs
dextroamphetamine
03
Conditions
attention deficit hyperactivity disorder (ADHD)
Beyond the preview
Go deeper on NCT05621174.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05621174.